To study the association between bone disease and long-term steroid administration in asthmatics, we reviewed the hospital records of 128 patients over 40 years of age who had taken daily or alternate-day adrenal corticosteroids for at least a year and compared them with the records of 54 other asthmatics of similar age who had not required long-term administration of steroids. We found evidence in the records of a total of 58 fractures of the ribs or vertebrae in 14 of the patients who had received long-term steroid treatment (11 per cent) and no evidence of fractures in the patients who had not received long-term treatment. We also prospectively studied 30 hospitalized asthmatic patients between 20 and 70 years of age who had been screened for medications (other than steroids) or complicating diseases known to affect bone mineralization. Eight of 19 asthmatic patients receiving long-term steroid therapy had rib or vertebral fractures, whereas none of 11 matched patients not receiving such therapy had fractures. Furthermore, bone-density measurements of the distal and proximal radius by photon absorptiometry revealed that the trabecular, but not the cortical, bone mass was below normal in the former group of patients but not in the latter. Within the long-term steroid group, there was no significant correlation between bone density and dose or duration of steroid treatment. We conclude that long-term steroid therapy in asthmatic patients is associated with decreased trabecular bone density and an increased prevalence of rib and vertebral fractures.
This article has been cited by other articles:
Chakhtoura, Z., Bachelot, A., Samara-Boustani, D., Ruiz, J.-C., Donadille, B., Dulon, J., Christin-Maitre, S., Bouvattier, C., Raux-Demay, M.-C., Bouchard, P., Carel, J.-C., Leger, J., Kuttenn, F., Polak, M., Touraine, P.
(2008). Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency.. Eur J Endocrinol
158: 879-887
[Abstract][Full Text]
Vestergaard, P., Rejnmark, L., Mosekilde, L.
(2007). Fracture Risk in Patients With Chronic Lung Diseases Treated With Bronchodilator Drugs and Inhaled and Oral Corticosteroids. Chest
132: 1599-1607
[Abstract][Full Text]
Syed, M.I., Patel, N.A., Jan, S., Shaikh, A., Grunden, B., Morar, K.
(2006). Symptomatic refractures after vertebroplasty in patients with steroid-induced osteoporosis.. Am. J. Neuroradiol.
27: 1938-1943
[Abstract][Full Text]
King, J. A., Wisniewski, A. B., Bankowski, B. J., Carson, K. A., Zacur, H. A., Migeon, C. J.
(2006). Long-Term Corticosteroid Replacement and Bone Mineral Density in Adult Women with Classical Congenital Adrenal Hyperplasia. J. Clin. Endocrinol. Metab.
91: 865-869
[Abstract][Full Text]
Summey, B. T., Yosipovitch, G.
(2006). Glucocorticoid-Induced Bone Loss in Dermatologic Patients: An Update. Arch Dermatol
142: 82-90
[Abstract][Full Text]
Bertoldo, F., Olivieri, M., Franchina, G., De Blasio, F., Lo Cascio, V.
(2005). Inhaled Beclomethasone Dipropionate Acutely Stimulates Dose-Dependent Growth Hormone Secretion in Healthy Subjects. Chest
128: 902-905
[Abstract][Full Text]
Rosen, J., Miner, J. N.
(2005). The Search for Safer Glucocorticoid Receptor Ligands. Endocr. Rev.
26: 452-464
[Abstract][Full Text]
Gonzalez-Moles, M.A., Scully, C.
(2005). Vesiculo-erosive Oral Mucosal Disease--Management with Topical Corticosteroids: (2) Protocols, Monitoring of Effects and Adverse Reactions, and the Future. J. Dent. Res.
84: 302-308
[Abstract][Full Text]
Campbell, I A, Douglas, J G, Francis, R M, Prescott, R J, Reid, D M
(2004). Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids. Thorax
59: 761-768
[Abstract][Full Text]
Schlienger, R. G., Jick, S. S., Meier, C. R.
(2004). Inhaled Corticosteroids and the Risk of Fractures in Children and Adolescents. Pediatrics
114: 469-473
[Abstract][Full Text]
Mandel, K., Atkinson, S., Barr, R. D., Pencharz, P.
(2004). Skeletal Morbidity in Childhood Acute Lymphoblastic Leukemia. JCO
22: 1215-1221
[Abstract][Full Text]
Ionescu, A.A., Schoon, E.
(2003). Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J
22: 64S-75s
[Abstract][Full Text]
Crawford, B. A. L., Liu, P. Y., Kean, M. T., Bleasel, J. F., Handelsman, D. J.
(2003). Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment. J. Clin. Endocrinol. Metab.
88: 3167-3176
[Abstract][Full Text]
Yeap, S. S., Hosking, D. J.
(2002). Management of corticosteroid-induced osteoporosis. Rheumatology (Oxford)
41: 1088-1094
[Abstract][Full Text]
Rubin, M. R., Bilezikian, J. P.
(2002). The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence. J. Clin. Endocrinol. Metab.
87: 4033-4041
[Full Text]
Walsh, L. J., Lewis, S. A., Wong, C. A., Cooper, S., Oborne, J., Cawte, S. A., Harrison, T., Green, D. J., Pringle, M., Hubbard, R., Tattersfield, A. E.
(2002). The Impact of Oral Corticosteroid Use on Bone Mineral Density and Vertebral Fracture. Am. J. Respir. Crit. Care Med.
166: 691-695
[Abstract][Full Text]
Vestergaard, P., Mosekilde, L.
(2002). Fracture Risk in Patients with Celiac Disease, Crohn's Disease, and Ulcerative Colitis: A Nationwide Follow-up Study of 16,416 Patients in Denmark. Am J Epidemiol
156: 1-10
[Abstract][Full Text]
Dubois, E. F., Roder, E., Dekhuijzen, P. N. R., Zwinderman, A. E., Schweitzer, D. H.
(2002). Dual Energy X-ray Absorptiometry Outcomes in Male COPD Patients After Treatment With Different Glucocorticoid Regimens*. Chest
121: 1456-1463
[Abstract][Full Text]
Biskobing, D. M.
(2002). COPD and Osteoporosis. Chest
121: 609-620
[Abstract][Full Text]
Gudbjornsson, B, Juliusson, U I, Gudjonsson, F V
(2002). Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis
61: 32-36
[Abstract][Full Text]
Matsumoto, H., Ishihara, K., Hasegawa, T., Umeda, B.-i., Niimi, A., Hino, M.
(2001). Effects of Inhaled Corticosteroid and Short Courses of Oral Corticosteroids on Bone Mineral Density in Asthmatic Patients : A 4-Year Longitudinal Study. Chest
120: 1468-1473
[Abstract][Full Text]
Yood, R. A., Harrold, L. R., Fish, L., Cernieux, J., Emani, S., Conboy, E., Gurwitz, J. H.
(2001). Prevention of Glucocorticoid-Induced Osteoporosis: Experience in a Managed Care Setting. Arch Intern Med
161: 1322-1327
[Abstract][Full Text]
Walsh, L J, Wong, C A, Oborne, J, Cooper, S, Lewis, S A, Pringle, M, Hubbard, R, Tattersfield, A E
(2001). Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax
56: 279-284
[Abstract][Full Text]
van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., Cooper, C.
(2000). Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford)
39: 1383-1389
[Abstract][Full Text]
Soyka, L. A., Fairfield, W. P., Klibanski, A.
(2000). Hormonal Determinants and Disorders of Peak Bone Mass in Children. J. Clin. Endocrinol. Metab.
85: 3951-3963
[Full Text]
Naganathan, V., Jones, G., Nash, P., Nicholson, G., Eisman, J., Sambrook, P. N.
(2000). Vertebral Fracture Risk With Long-term Corticosteroid Therapy: Prevalence and Relation to Age, Bone Density, and Corticosteroid Use. Arch Intern Med
160: 2917-2922
[Abstract][Full Text]
LLOYD, M E, SPECTOR, T D, HOWARD, R
(2000). Osteoporosis in neurological disorders. J. Neurol. Neurosurg. Psychiatry
68: 543-547
[Full Text]
Medici, T C, Grebski, E, Häcki, M, Rüegsegger, P, Maden, C, Efthimiou, J
(2000). Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects. Thorax
55: 375-382
[Abstract][Full Text]
Evans, S F, Davie, M W J
(2000). Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men. Ann Rheum Dis
59: 269-275
[Abstract][Full Text]
Vestergaard, P, Krogh, K, Rejnmark, L, Laurberg, S, Mosekilde, L
(2000). Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut
46: 176-181
[Abstract][Full Text]
Goldstein, M. F., Fallon, J. J. Jr, Harning, R.
(1999). Chronic Glucocorticoid Therapy-Induced Osteoporosis in Patients With Obstructive Lung Disease*. Chest
116: 1733-1749
[Abstract][Full Text]
Gohel, A., McCarthy, M.-B., Gronowicz, G.
(1999). Estrogen Prevents Glucocorticoid-Induced Apoptosis in Osteoblasts in Vivo and in Vitro. Endocrinology
140: 5339-5347
[Abstract][Full Text]
Reid, I. R.
(1999). Glucocorticoid Osteoporosis: Reid IR Glucocorticoid osteoporosis J Intensive Care Med 1999, 14231-242. J Intensive Care Med
14: 231-242
Miller, K. K., Klibanski, A.
(1999). Amenorrheic Bone Loss. J. Clin. Endocrinol. Metab.
84: 1775-1783
[Full Text]
LAATIKAINEN, A. K., KROGER, H. P. J., TUKIAINEN, H. O., HONKANEN, R. J., SAARIKOSKI, S. V.
(1999). Bone Mineral Density in Perimenopausal Women with Asthma . A Population-based Cross-sectional Study. Am. J. Respir. Crit. Care Med.
159: 1179-1185
[Abstract][Full Text]
Geusens, P., Dequeker, J., Vanhoof, J., Stalmans, R., Boonen, S., Joly, J., Nijs, J., Raus, J.
(1998). Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study. Ann Rheum Dis
57: 724-727
[Abstract][Full Text]
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., Czachur, M., Daifotis, A. G., Lane, N., Correa-Rotter, R., Yanover, M., Westhovens, R., Epstein, S., Adachi, J. D., Poubelle, P., Melo-Gomes, J., Rodriguez-Portales, J. A., The Glucocorticoid-Induced Osteoporosis Interventi,
(1998). Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. NEJM
339: 292-299
[Abstract][Full Text]
Traianedes, K., Dallas, M. R., Garrett, I. R., Mundy, G. R., Bonewald, L. F.
(1998). 5-Lipoxygenase Metabolites Inhibit Bone Formation in Vitro. Endocrinology
139: 3178-3184
[Abstract][Full Text]
COWAN, S., MORIN, S., ERNST, P.
(1998). Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases. Thorax
53: 331-332
[Full Text]
Pitt, P, Li, F, Todd, P, Webber, D, Pack, S, Moniz, C
(1998). A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment. Thorax
53: 351-356
[Abstract][Full Text]
Roux, C., Oriente, P., Laan, R., Hughes, R. A., Ittner, J., Goemaere, S., Di Munno, O., Pouillès, J. M., Horlait, S., Cortet, B.
(1998). Randomized Trial of Effect of Cyclical Etidronate in the Prevention of Corticosteroid-Induced Bone Loss. J. Clin. Endocrinol. Metab.
83: 1128-1133
[Abstract][Full Text]
BARNES, P. J., PEDERSEN, S., BUSSE, W. W.
(1998). Efficacy and Safety of Inhaled Corticosteroids . New Developments. Am. J. Respir. Crit. Care Med.
157: S1-53
[Full Text]
MCEVOY, C. E., ENSRUD, K. E., BENDER, E., GENANT, H. K., YU, W., GRIFFITH, J. M., NIEWOEHNER, D. E.
(1998). Association between Corticosteroid Use and Vertebral Fractures in Older Men with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med.
157: 704-709
[Abstract][Full Text]
PAUWELS, R. A., YERNAULT, J. C., DEMEDTS, M. G., GEUSENS, P.
(1998). Safety and Efficacy of Fluticasone and Beclomethasone in Moderate to Severe Asthma. Am. J. Respir. Crit. Care Med.
157: 827-832
[Abstract][Full Text]
KINÉ, D A H, MAEYENS, E, TWOMEY;, J M, HODGKINS, P, HULL, R G
(1998). Osteoporosis: a survey of consultant ophthalmologists. Br. J. Ophthalmol.
82: 203a-203
[Full Text]
BIJLSMA, J. W J
(1997). Prevention of glucocorticoid induced osteoporosis. Ann Rheum Dis
56: 507-509
[Full Text]
Lems, W. F, Jacobs, J. W G, Bijlsma, J. W J, van Veen, G. J M, Houben, H. H M L, Haanen, H. C M, Gerrits, M. I, van Rijn, H. J M
(1997). Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?. Ann Rheum Dis
56: 357-363
[Abstract][Full Text]
AGERTOFT, L., PEDERSEN, S.
(1997). Bone Mineral Density in Children with Asthma Receiving Long-term Treatment with Inhaled Budesonide. Am. J. Respir. Crit. Care Med.
157: 178-183
[Abstract][Full Text]
Walsh, L J, Wong, C A, Pringle, M, Tattersfield, A E
(1996). Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ
313: 344-346
[Abstract][Full Text]
Sambrook, P., Birmingham, J., Kelly, P., Kempler, S., Nguyen, T., Pocock, N., Eisman, J.
(1993). Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin. NEJM
328: 1747-1752
[Abstract][Full Text]
Previous
